Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00244374 · ClinicalTrials.gov registry record · NA
A Randomized Trial of Vaccine Adherence in Young Injection Drug Users
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 546
- Enrollment target
NCT00244374: Completed NA study, sponsored by University of California, San Francisco.
NCT00244374 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 546 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00244374, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 546 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of (a) immunization setting and (b) outreach worker support on young injection drug users' (IDU) adherence to a multiple dose immunization schedule with a combined hepatitis A virus (HAV) inactivated and hepatitis B virus (HBV) recombinant vaccine.
Primary Outcome
The primary outcome was the completion of the four-dose vaccine series in a 12 month period.
Interventions
- BIOLOGICAL Hepatitis A & B vaccine
- BEHAVIORAL Outreach
- BEHAVIORAL AIC
- BEHAVIORAL SEP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 546 participants |
| Start Date | 2004-08 |
| Est. Completion | 2008-06 |
| Phase | NA |
What the finished NCT00244374 record still lists
NCT00244374 is an interventional study that assigns participants to a tested intervention. The registered 546 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 4 interventions - of which Hepatitis A & B vaccine is the first listed.
NCT00244374 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00244374 about?
NCT00244374 is a clinical study titled "A Randomized Trial of Vaccine Adherence in Young Injection Drug Users". The purpose of this study is to compare the effects of (a) immunization setting and (b) outreach worker support on young injection drug users' (IDU) adherence to a multiple dose immunization schedule with a combined hepatitis A virus (HAV) inactivated and hepatitis B virus (HBV) recombinant vaccine.
What is the current status of trial NCT00244374?
This trial is currently completed. It is a NA study. The enrollment target is 546 participants. The study started on 2004-08. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00244374?
The interventions under investigation include: Hepatitis A & B vaccine (BIOLOGICAL), Outreach (BEHAVIORAL), AIC (BEHAVIORAL), SEP (BEHAVIORAL).
Who is sponsoring clinical trial NCT00244374?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00244374's enrollment target sits among peer trials
546 186th of 2000 higher than 1,815 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03572374 · 546 participants · NA
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
- NCT05937685 · 546 participants · NA
Reducing Blood Pressure in Patients With High Cardiovascular Risk
- NCT06416150 · 546 participants · NA
Reducing Urban Cervical Cancer Disparities
- NCT06850922 · 546 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia